|国家预印本平台
首页|An auto-inhibited state of protein kinase G and implications for selective activation

An auto-inhibited state of protein kinase G and implications for selective activation

An auto-inhibited state of protein kinase G and implications for selective activation

来源:bioRxiv_logobioRxiv
英文摘要

Abstract Cyclic GMP-dependent protein kinases (PKGs) are key mediators of the nitric oxide/cGMP signaling pathway that regulates biological functions as diverse as smooth muscle contraction, cardiac function, and axon guidance. Campaigns targeting nitric oxide synthases and cyclic nucleotide phosphodiesterases in this signaling axis suggest that understanding how cGMP differentially triggers mammalian PKG isoforms could lead to new therapeutics that inhibit or activate PKGs. Alternate splicing of PRKG1 transcripts confers distinct leucine zippers, linkers, and auto-inhibitory pseudo-substrate sequences to PKG Iα and Iβ that result in isoform-specific activation properties, but the mechanism of enzyme auto-inhibition and its alleviation by cGMP is still not well understood. Here we present a crystal structure of PKG Iβ in which the auto-inhibitory sequence and the cyclic nucleotide binding domains are bound to the catalytic domain, providing a snapshot of the auto-inhibited state. Specific contacts between the PKG Iβ auto-inhibitory sequence and the enzyme active site help explain isoform-specific activation constants and the effects of phosphorylation in the linker. We also present a crystal structure of a PKG I cyclic nucleotide binding domain with an activating mutation linked to Thoracic Aortic Aneurysms and Dissections. Similarity of this structure to wild type cGMP-bound domains and differences with the auto-inhibited enzyme provide a mechanistic basis for constitutive activation. We show that PKG Iβ auto-inhibition is mediated by contacts within each monomer of the native full-length dimeric protein, and using the available structural and biochemical data we develop a model for the regulation and activation of PKGs.

Qin Liying、Henning Philipp、VanSchouwen Bryan、Kaur Gundeep、MacKenzie Kevin R.、Melacini Giuseppe、Kim Choel、Sharma Rajesh、Kim Jeong Joo、Akimoto Madoka、Sankaran Banumathi、Casteel Darren E.、Herberg Friedrich W.

Department of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of MedicineDepartment of Biochemistry, University of KasselDepartment of Chemistry and Chemical Biology, McMaster UniversityDepartment of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of MedicineDepartment of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of Medicine||Department of Pathology and Immunology and Center for Drug Discovery, Baylor College of MedicineDepartment of Chemistry and Chemical Biology, McMaster UniversityDepartment of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of Medicine||Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of MedicineDepartment of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of MedicineDepartment of Pharmacology and Chemical Biology and Center for Drug Discovery, Baylor College of MedicineDepartment of Chemistry and Chemical Biology, McMaster UniversityBerkeley Center for Structural Biology, Lawrence Berkeley National LaboratoryDepartment of Medicine, University of CaliforniaDepartment of Biochemistry, University of Kassel

10.1101/2022.04.28.489861

基础医学生物化学分子生物学

cGMP signalingkinase regulation and activationmammalian signal transductionsecond messengerTAAD

Qin Liying,Henning Philipp,VanSchouwen Bryan,Kaur Gundeep,MacKenzie Kevin R.,Melacini Giuseppe,Kim Choel,Sharma Rajesh,Kim Jeong Joo,Akimoto Madoka,Sankaran Banumathi,Casteel Darren E.,Herberg Friedrich W..An auto-inhibited state of protein kinase G and implications for selective activation[EB/OL].(2025-03-28)[2025-05-21].https://www.biorxiv.org/content/10.1101/2022.04.28.489861.点此复制

评论